Suppr超能文献

大鼠肾上腺素诱导肺水肿的研究。I. 选择性α1-肾上腺素能受体的参与。

Studies on epinephrine-induced lung edema in the rat. I. Selective alpha 1-adrenoceptor involvement.

作者信息

Ferrari W, Baggio G, Guarini S

出版信息

Arch Int Pharmacodyn Ther. 1986 May;281(1):89-99.

PMID:3019261
Abstract

Phentolamine (Phe) prevents the induction by epinephrine (E: 1800 nmol/kg, i.v.) of lung edema (LE) in urethane-anesthetized and bivagotomized rats in a dose-related manner (from 246 to 3933 nmol/kg, i.v.). Since Phe blocks and E activates both alpha 1- and alpha 2-adrenoceptors, the evidence does not allow us to link LE to selective (alpha 1 or alpha 2) or non-selective (alpha 1 + alpha 2) alpha-adrenoceptor activation. Accordingly, we tried to find out whether: phenylephrine (PE), a selective alpha 1-adrenoceptor agonist, and B-HT 920, a selective alpha 2-adrenoceptor agonist, would cause LE; prazosin (Praz), a selective alpha 1-adrenoceptor antagonist, and yohimbine (Yoh), a selective alpha 2-adrenoceptor antagonist, would protect rats against LE caused by E or PE. We found that: 1) PE (from 736 to 5892 nmol/kg, i.v.), but not B-HT 920 (from 190 to 12200 nmol/kg, i.v.), caused LE, while both drugs increased arterial blood pressure; 2) Praz prevented induction of LE, whether by E (1800 nmol/kg, i.v.) or by PE (5892 nmol/kg, i.v.), in a dose-related manner (from 15 to 119 nmol/kg, i.v.). In contrast, Yoh was ineffective at doses up to 7675 nmol/kg, i.v. We conclude, therefore, that E-induced LE in urethane-anesthetized and bivagotomized rats strictly depends on alpha 1-adrenoceptor activation. The outcome of E-induced LE is usually rat death, the incidence of which depends on the dose. Since alpha 1-adrenoceptor agonists rank in the same order of potency for the induction of death as for that of LE, and since Phe and Praz protect from death at LE-preventing doses, there seems to be some link between LE and death, even though protection against death is obtained with doses of antagonists lower than those abolishing induction of LE. Finally, alpha 1-agonists cause maximum arterial hypertension at all doses used, irrespective of induction of LE and of protective pretreatment against LE.

摘要

酚妥拉明(Phe)能以剂量相关方式(静脉注射剂量为246至3933 nmol/kg)预防肾上腺素(E:1800 nmol/kg,静脉注射)诱发的乌拉坦麻醉和双侧迷走神经切断大鼠的肺水肿(LE)。由于Phe能阻断而E能激活α1和α2肾上腺素能受体,因此现有证据无法让我们将肺水肿与选择性(α1或α2)或非选择性(α1 + α2)α肾上腺素能受体激活联系起来。因此,我们试图弄清楚:选择性α1肾上腺素能受体激动剂去氧肾上腺素(PE)和选择性α2肾上腺素能受体激动剂B-HT 920是否会引起肺水肿;选择性α1肾上腺素能受体拮抗剂哌唑嗪(Praz)和选择性α2肾上腺素能受体拮抗剂育亨宾(Yoh)是否能保护大鼠免受E或PE引起的肺水肿。我们发现:1)PE(静脉注射剂量为736至5892 nmol/kg)可引起肺水肿,而B-HT 920(静脉注射剂量为190至12200 nmol/kg)则不会,不过两种药物都会使动脉血压升高;2)Praz能以剂量相关方式(静脉注射剂量为15至119 nmol/kg)预防E(1800 nmol/kg,静脉注射)或PE(5892 nmol/kg,静脉注射)诱发的肺水肿。相比之下,Yoh在静脉注射剂量高达7675 nmol/kg时无效。因此,我们得出结论,乌拉坦麻醉和双侧迷走神经切断大鼠中E诱发的肺水肿严格依赖于α1肾上腺素能受体激活。E诱发的肺水肿的结果通常是大鼠死亡,其发生率取决于剂量。由于α1肾上腺素能受体激动剂诱发死亡的效力顺序与诱发肺水肿的顺序相同,并且由于Phe和Praz在预防肺水肿的剂量下能预防死亡,所以即使使用低于消除肺水肿诱发剂量的拮抗剂就能获得对死亡的保护,但肺水肿和死亡之间似乎存在某种联系。最后,α1激动剂在所有使用剂量下都会引起最大程度动脉高血压,无论是否诱发肺水肿以及是否对肺水肿进行保护性预处理。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验